Prevalence of many comorbidities is similar irrespective of the time since HIV diagnosis in persons ageing with HIV who have survived to age 65 years
HIV Medicine · 31.10.2026
DOI: 10.1111/hiv.70344 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, online erschienen am 31.10.2026. Verfasst von Alice Zhabokritsky und 14 weiteren Autor:innen. Beteiligte Einrichtung: University Health Network, Toronto, Ontario, Canada. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institute of Health Research, Canadian HIV Clinical Trials Network.
Abstract (Originalsprache)
Objective
To compare the prevalence of comorbidity in persons with HIV ≥65 years of age based on the time from HIV diagnosis.
Design
Cross‐sectional observational cohort study.
Methods
Data was collected from 540 participants in the CHANGE HIV (Correlates of Healthy Aging in Geriatric HIV) study, a longitudinal study of HIV in persons aged 65 years and older from seven primary and tertiary care centres in Canada between 2019 and 2026. We compared the baseline prevalence of comorbidities stratified by the cumulative time since known HIV diagnosis (30 years) and controlled for demographic, HIV and lifestyle factors.
Results
The cohort was 90% male, median age 69 years, 76% white, median CD4 561 cells/mm 3 and 92% with an undetectable viral load. They had a median of 3 (range 0–12) comorbid conditions. There was no difference in prevalence of coronary artery disease, dyslipidaemia, peripheral artery disease, stroke, chronic obstructive lung disease, asthma, arthritis, Parkinson's disease, HIV‐associated neurocognitive dysfunction, chronic kidney disease, diabetes or liver disease based on time since HIV diagnosis. After accounting for confounders, longer time since HIV diagnosis was associated with higher prevalence of cancer, diabetes and peripheral neuropathy. Of the comorbidities only peripheral neuropathy, dyslipidaemia and Kaposi's sarcoma occurred at a younger age.
Conclusions
Prevalence of many comorbidities was not increased in those with longer time since HIV diagnosis. Lifestyle factors (smoking, substance use and diet) are important contributors to non‐infectious comorbidities in this population, and increased prevalence of cancer reinforces the importance of preventative screening.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Health Network, Toronto, Ontario, Canada.
- University of Toronto, Toronto, Ontario, Canada.
- Biostatistical Research Unit, University Health Network, Toronto, Ontario, Canada.
- McGill University, Montreal, Quebec, Canada.
- Maple Leaf Medical, Toronto, Ontario, Canada.
- British Columbia Center for Excellence in HIV, University of British Columbia, Toronto, Ontario, Canada.
ORCID-Profile: Alice Zhabokritsky, Leif Erik Lovblom, Marina Klein, Marianne Harris, Giovanni Guaraldi, Sharon Walmsley
Förderung
- Canadian Institute of Health Research
- Canadian HIV Clinical Trials Network
Zitieren
APA
Zhabokritsky, A., Lovblom, L. E., Boyachuk, B., Falutz, J., Klein, M., Loutfy, M., Smith, G., Tan, D., Harris, M., Guillemi, S., Adany, N., Verway, M., Arbess, G., Guaraldi, G., & Walmsley, S. (2026). Prevalence of many comorbidities is similar irrespective of the time since HIV diagnosis in persons ageing with HIV who have survived to age 65 years. HIV Medicine. https://doi.org/10.1111/hiv.70344
Vancouver
Zhabokritsky A, Lovblom LE, Boyachuk B, Falutz J, Klein M, Loutfy M, et al. Prevalence of many comorbidities is similar irrespective of the time since HIV diagnosis in persons ageing with HIV who have survived to age 65 years. HIV Medicine. 2026. doi:10.1111/hiv.70344
BibTeX
@article{Zhabokritsky2026,
author = {Zhabokritsky, Alice and Lovblom, Leif Erik and Boyachuk, Brian and Falutz, Julien and Klein, Marina and Loutfy, Mona and Smith, Graham and Tan, Darrell and Harris, Marianne and Guillemi, Sylvia and Adany, Nisha and Verway, Mark and Arbess, Gord and Guaraldi, Giovanni and Walmsley, Sharon},
title = {Prevalence of many comorbidities is similar irrespective of the time since HIV diagnosis in persons ageing with HIV who have survived to age 65 years},
journal = {HIV Medicine},
year = {2026},
doi = {10.1111/hiv.70344}
}
EUVIMED